These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 29983117)

  • 1. Association of medullary sponge kidney and hyperparathyroidism with RET G691S/S904S polymorphism: a case report.
    Janjua MU; Long XD; Mo ZH; Dong CS; Jin P
    J Med Case Rep; 2018 Jul; 12(1):197. PubMed ID: 29983117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An unusual association of contralateral congenital small kidney, reduced renal function and hyperparathyroidism in sponge kidney patients: on the track of the molecular basis.
    Gambaro G; Fabris A; Citron L; Tosetto E; Anglani F; Bellan F; Conte M; Bonfante L; Lupo A; D'Angelo A
    Nephrol Dial Transplant; 2005 Jun; 20(6):1042-7. PubMed ID: 15814540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haplotype Frequency of G691S/S904S in the RET Proto-Onco-gene in Patients with Medullary Thyroid Carcinoma.
    Sheikholeslami S; Zarif Yeganeh M; Hoghooghi Rad L; Golab Ghadaksaz H; Hedayati M
    Iran J Public Health; 2014 Feb; 43(2):235-40. PubMed ID: 26060748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New non-renal congenital disorders associated with medullary sponge kidney (MSK) support the pathogenic role of GDNF and point to the diagnosis of MSK in recurrent stone formers.
    Ria P; Fabris A; Dalla Gassa A; Zaza G; Lupo A; Gambaro G
    Urolithiasis; 2017 Aug; 45(4):359-362. PubMed ID: 27573101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of GDNF gene sequence variations in patients with medullary sponge kidney disease.
    Torregrossa R; Anglani F; Fabris A; Gozzini A; Tanini A; Del Prete D; Cristofaro R; Artifoni L; Abaterusso C; Marchionna N; Lupo A; D'Angelo A; Gambaro G
    Clin J Am Soc Nephrol; 2010 Jul; 5(7):1205-10. PubMed ID: 20448065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Possible Impact of RET Polymorphism and Its Haplotypic Association Modulates the Susceptibility to Thyroid Cancer.
    Khan MS; Pandith AA; Iqbal M; Naykoo NA; Khan SH; Rather TA; Mudassar S
    J Cell Biochem; 2015 Aug; 116(8):1712-8. PubMed ID: 25736215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nationwide French Study of RET Variants Detected from 2003 to 2013 Suggests a Possible Influence of Polymorphisms as Modifiers.
    Lebeault M; Pinson S; Guillaud-Bataille M; Gimenez-Roqueplo AP; Carrie A; Barbu V; Pigny P; Bezieau S; Rey JM; Delvincourt C; Giraud S; Veyrat-Durebex C; Saulnier P; Bouzamondo N; Chabbert M; Blin J; Mohamed A; Romanet P; Borson-Chazot F; Rohmer V; Barlier A; Mirebeau-Prunier D
    Thyroid; 2017 Dec; 27(12):1511-1522. PubMed ID: 28946813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical relevance of RET variants G691S, L769L, S836S and S904S to sporadic medullary thyroid cancer.
    Machens A; Frank-Raue K; Lorenz K; Rondot S; Raue F; Dralle H
    Clin Endocrinol (Oxf); 2012 May; 76(5):691-7. PubMed ID: 22111543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The G691S RET polymorphism increases glial cell line-derived neurotrophic factor-induced pancreatic cancer cell invasion by amplifying mitogen-activated protein kinase signaling.
    Sawai H; Okada Y; Kazanjian K; Kim J; Hasan S; Hines OJ; Reber HA; Hoon DS; Eibl G
    Cancer Res; 2005 Dec; 65(24):11536-44. PubMed ID: 16357163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional characterization of the MTC-associated germline RET-K666E mutation: evidence of oncogenic potential enhanced by the G691S polymorphism.
    Borrello MG; Aiello A; Peissel B; Rizzetti MG; Mondellini P; Degl'Innocenti D; Catalano V; Gobbo M; Collini P; Bongarzone I; Pierotti MA; Greco A; Seregni E
    Endocr Relat Cancer; 2011 Aug; 18(4):519-27. PubMed ID: 21690267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medullary sponge kidney: state of the art.
    Fabris A; Anglani F; Lupo A; Gambaro G
    Nephrol Dial Transplant; 2013 May; 28(5):1111-9. PubMed ID: 23229933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Germline gene testing of the RET, VHL, SDHD and SDHB genes in patients with pheochromocytoma/paraganglioma].
    Wu K; Zhang Y; Zhang H; Tan ZH; Guo XH; Yang JM
    Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Aug; 50(4):634-639. PubMed ID: 30122763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single nucleotide polymorphisms act as modifiers and correlate with the development of medullary and simultaneous medullary/papillary thyroid carcinomas in 2 large, non-related families with the RET V804M proto-oncogene mutation.
    Shifrin AL; Ogilvie JB; Stang MT; Fay AM; Kuo YH; Matulewicz T; Xenachis CZ; Vernick JJ
    Surgery; 2010 Dec; 148(6):1274-80; discussion 1280-1. PubMed ID: 21134561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RET exon 11 (G691S) polymorphism is significantly more frequent in sporadic medullary thyroid carcinoma than in the general population.
    Elisei R; Cosci B; Romei C; Bottici V; Sculli M; Lari R; Barale R; Pacini F; Pinchera A
    J Clin Endocrinol Metab; 2004 Jul; 89(7):3579-84. PubMed ID: 15240649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymorphisms in the initiators of RET (rearranged during transfection) signaling pathway and susceptibility to sporadic medullary thyroid carcinoma.
    Cebrian A; Lesueur F; Martin S; Leyland J; Ahmed S; Luccarini C; Smith PL; Luben R; Whittaker J; Pharoah PD; Dunning AM; Ponder BA
    J Clin Endocrinol Metab; 2005 Nov; 90(11):6268-74. PubMed ID: 16091499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discrepancies of RET gene and risk of differentiated thyroid carcinoma.
    Rashid FA; Khan MS; Tabassum S; Aiman A; Jadoon MH
    Cancer Biomark; 2022; 33(1):111-121. PubMed ID: 34366324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of RET genetic polymorphisms and haplotypes with papillary thyroid carcinoma in the Portuguese population: a case-control study.
    Santos M; Azevedo T; Martins T; Rodrigues FJ; Lemos MC
    PLoS One; 2014; 9(10):e109822. PubMed ID: 25330015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The modifier role of RET-G691S polymorphism in hereditary medullary thyroid carcinoma: functional characterization and expression/penetrance studies.
    Colombo C; Minna E; Rizzetti MG; Romeo P; Lecis D; Persani L; Mondellini P; Pierotti MA; Greco A; Fugazzola L; Borrello MG
    Orphanet J Rare Dis; 2015 Mar; 10():25. PubMed ID: 25887804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphisms in exon 13 and intron 14 of the RET protooncogene: genetic modifiers of medullary thyroid carcinoma?
    Baumgartner-Parzer SM; Lang R; Wagner L; Heinze G; Niederle B; Kaserer K; Waldhäusl W; Vierhapper H
    J Clin Endocrinol Metab; 2005 Nov; 90(11):6232-6. PubMed ID: 16118333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of RET genetic variants in MEN2-associated pheochromocytoma.
    Siqueira DR; Ceolin L; Ferreira CV; Romitti M; Maia SC; Maciel LM; Maia AL
    Eur J Endocrinol; 2014 Jun; 170(6):821-8. PubMed ID: 24616415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.